Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, 28 February 2019 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced an increase of the number of shares and votes in NeuroVive of 71,661,048 as a result of a partial registration of the preferential rights issue, resolved by the Board of Directors on 10 December 2018 and approved at the Extraordinary General Meeting on 17 January 2019.Today, the last trading day of the month, there are in total 163,358,124 shares and votes in NeuroVive Pharmaceutical AB. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to